Home > Insider Trading > Filing (0000899243-19-017818)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1217234	Caredx Inc.	CDNA	Services-Medical Laboratories (8071)	943316839

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1702824	Brian Michael Bell	C/O Caredx, Inc. 3260 Bayshore Boulevard Brisbane CA 94005	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-06-20	834	$1.00	71,734	No	4	M	Direct
Common Stock	Acquisiton	2019-06-20	139	$2.80	71,873	No	4	M	Direct
Common Stock	Acquisiton	2019-06-20	937	$5.90	72,810	No	4	M	Direct
Common Stock	Acquisiton	2019-06-20	292	$6.31	73,102	No	4	M	Direct
Common Stock	Acquisiton	2019-06-20	12,500	$12.24	85,602	No	4	M	Direct
Common Stock	Disposition	2019-06-20	14,702	$38.81	70,900	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2019-06-20	834	$0.00	834	$1.00
Common Stock	Employee Stock Option (right to buy)	Disposition	2019-06-20	139	$0.00	139	$2.80
Common Stock	Employee Stock Option (right to buy)	Disposition	2019-06-20	937	$0.00	937	$5.90
Common Stock	Employee Stock Option (right to buy)	Disposition	2019-06-20	292	$0.00	292	$6.31
Common Stock	Employee Stock Option (right to buy)	Disposition	2019-06-20	12,500	$0.00	12,500	$12.24

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
19,167	2027-04-21	No	4	M	Direct
3,889	2027-09-01	No	4	M	Direct
27,188	2027-10-27	No	4	M	Direct
9,342	2028-01-19	No	4	M	Direct
37,500	2028-06-29	No	4	M	Direct

Footnotes

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.76 to $40.49, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
1/4th of the shares subject to the option vested on April 21, 2018 and 1/48th of the shares subject to the option vest monthly thereafter.
1/2 of the shares subject to the option vested on September 1, 2018 and 1/72nd of the shares subject to the option vest monthly thereafter.
1/4th of the shares subject to the option vested on October 20, 2018 and 1/48th of the shares subject to the option vest monthly thereafter.
1/4th of the shares subject to the option vested on January 19, 2019 and 1/48th of the shares subject to the option vest monthly thereafter.
1/4th of the shares subject to the option shall vest on June 1, 2019 and 1/48th of the shares subject to the option shall vest monthly thereafter.